AMANTA vs KPL: Stock Comparison

AMANTA vs KWALITY PHARMACEUTICALS LUpdated 16 Jun 26, 4:08 PM ISTNSE & company filings

KWALITY PHARMACEUTICALS L is the larger company by market capitalisation. AMANTA shows faster revenue growth, while KWALITY PHARMACEUTICALS L shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMANTA leads 2; KPL leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMANTAKPL

Valuation lens

What price are you paying?

Market CapContext only
₹749 Cr
₹3,598 Cr
P/E RatioKPL has the lower reading
53.58x
43.4x
P/B RatioAMANTA has the lower reading
3.57x
10.61x
EPSKPL has the higher reading
₹0.85
₹24.7
Book ValueContext only
₹56.71
₹317.96
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
KPL is the larger company
₹3,598 Cr vs ₹749 Cr
P/E Ratio
KPL has a lower P/E
43.4x vs 53.58x
P/B Ratio
AMANTA has a lower P/B
3.57x vs 10.61x
EPS
KPL has higher earnings per share
₹24.7 vs ₹0.85
Revenue Growth (TTM YoY)
AMANTA has faster revenue growth
6.8% vs 0%
EPS Growth (TTM YoY)
KPL has faster EPS growth
0% vs -23.4%
Qtr Sales Growth
KPL has stronger quarterly sales growth
0% vs -76.08%
Qtr Profit Growth
KPL has stronger quarterly profit growth
0.02% vs -77.74%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMANTAKPL
SectorHealthcare
IndustryPharmaceuticals

Price

MetricAMANTAKPL
Live Price₹150.27₹3,467
Day Change-4.37%3.31%
Volume3.82 L14,486
52-Week High₹164₹3,798.9
52-Week Low₹92₹1,561
Distance from 52W High-8.37%-8.74%

Valuation

MetricAMANTAKPL
Market Cap₹749 Cr₹3,598 Cr
P/E Ratio53.58x43.4x
P/B Ratio3.57x10.61x
EPS₹0.85₹24.7
Book Value₹56.71₹317.96
Dividend Yield0%0%

Growth

MetricAMANTAKPL
Revenue Growth (TTM YoY)6.8%0%
EPS Growth (TTM YoY)-23.4%0%
Qtr Sales Growth-76.08%0%
Qtr Profit Growth-77.74%0.02%

Profitability & Leverage

MetricAMANTAKPL
ROE6.75%20.41%
ROCE7.89%17.47%
Net Margin5.17%13.39%
Operating Margin14.55%19.97%
Debt to Equity1.06x0.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMANTAKPL
Promoter Holding26.87% 0.06 pp54.86% 0.01 pp
FII Holding0.43% 0.42 pp3.13% 0.34 pp
DII Holding12.92% 0.04 pp0.56% 0.2 pp
Public Holding22.85% 0.29 pp41.44% 0.54 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMANTA and KWALITY PHARMACEUTICALS L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.